Experience

Kristin VanderPas

    • Vir Biotechnology - $143 Million IPO 


    • Exagen Diagnostics – $58 Million IPO  


    • 10X Genomics – $449 Million IPO  


    • Livongo Health - $409 Million IPO 


    • Health Catalyst - $209 Million IPO 


    • Medallia - $374 Million IPO 


    • Mirum Pharmaceuticals - $75 Million IPO 


    • Uber Technologies $8.1 Billion IPO 


    • Precision BioSciences $145 Million IPO 


    • ShockWave Medical – $111 Million IPO 


    • Gossamer Bio – $317 Million IPO 


    • Allogene Therapeutics – $372.6 Million IPO 


    • Gritstone Oncology – $100 Million IPO 


    • Sutro Biopharma – $85 Million IPO 


    • Guardant Health – $273.1 Million IPO 


    • Eidos Therapeutics – $122 Million IPO 


    • Crinetics Pharmaceuticals – $117 Million IPO 


    • Aridis – $26 Million IPO 


    • Gemphire Therapeutics – $30 Million IPO 


    • Tricida – $256 Million IPO 


    • Atlassian - $531 Million IPO 


    • NantKwest IPO - $238 Million IPO 


    • ProNAi Therapeutics - $158 Million IPO 


    • NantKwest – $238 Million IPO 


    • ProNAi – $158 Million IPO 


    • MINDBODY Completes $100 Million IPO 


    • MINDBODY Completes $100 Million IPO 


    • FireEye Completes 144A Private Placement of $920 Million Convertible Senior Notes 


    • FireEye Completes 144A Private Placement of $920 Million Convertible Senior Notes 


    • Apigee Completes Initial Public Offering 


    • InsideSales.com Tops $200 Million in Capital with Latest $60 Million Round 


    • Invitae Completes $117 Million Initial Public Offering  


    • Ascendis Pharma closes $124 million IPO 


    • TRACON Pharmaceuticals Completes Initial Public Offering 


    • Cooley Advises Xencor on its Initial Public Offering 


    • Xenon Pharmaceuticals Completes Initial Public Offering 


    • Demira Prices $125 Million IPO 


    • Otonomy $100 Million IPO 


    • Immune Design $63 Million Initial Public Offering 


    • HealthEquity $146 Million Initial Public Offering 


    • Jazz Pharmaceuticals – $575 Million Exchangeable Senior Note Offering 


    • Minerva Neurosciences $32.7 Million IPO 


    • Kite Pharma $146 Million Initial Public Offering 


    • Vital Therapies Initial Public Offering 


    • Cooley Advises Underwriters on Vital Therapies IPO 


    • Amedica Initial Public Offering 


    • Celladon Initial Public Offering 


    • Xencor Initial Public Offering 


    • Five Prime Therapeutics IPO 


    • Receptos, Inc. Initial Public Offering